5-HT3 blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
04 Sep 2020
Historique:
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 25 9 2020
Statut: ppublish

Résumé

Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT3) blockade. Our aim was to assess if routine prophylactic administration of the 5-HT3 antagonist ondansetron (ODS) attenuates postspinal change in maternal blood pressure.Elective CS under SpA were retrospectively analyzed. Eighty parturients having routinely received 8 mg ODS prior to SpA were compared with 80 patients having not (control group).Mean arterial blood pressure significantly decreased from baseline to the postspinal period (P < .0001) without differences in blood pressure decreases between the 2 groups. This also applied to the heart rate. Overall use of cafedrine/theodrenaline was higher in the ODS group (0.8 (0.4-1.6) mL vs 0.8 (0-1.0) mL in the control group, P = .01). APGAR values showed a presumably clinically irrelevant decrease in control group compared with the ODS group.Our results suggest that routine administration of ODS in a dosage of 8 mg does not effectively attenuate postspinal change in maternal blood pressure during CS in our setting. Given the wide variability of anesthetic techniques, only large prospective and randomized multicenter trials will ultimately serve to elucidate this issue.

Identifiants

pubmed: 32899016
doi: 10.1097/MD.0000000000021864
pii: 00005792-202009040-00028
pmc: PMC7478381
doi:

Substances chimiques

Serotonin 5-HT3 Receptor Antagonists 0
Ondansetron 4AF302ESOS

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21864

Références

Anesth Analg. 2016 Oct;123(4):977-88
pubmed: 27537930
Reg Anesth Pain Med. 2008 Jul-Aug;33(4):332-9
pubmed: 18675744
J Med Assoc Thai. 2006 Sep;89 Suppl 3:S58-64
pubmed: 17718270
Minerva Ginecol. 2010 Dec;62(6):515-24
pubmed: 21079573
Anaesthesia. 2018 Jan;73(1):71-92
pubmed: 29090733
J Med Assoc Thai. 2006 Aug;89(8):1127-32
pubmed: 17048420
Anesthesiology. 2016 Feb;124(2):270-300
pubmed: 26580836
Int J Clin Exp Med. 2014 Dec 15;7(12):5210-6
pubmed: 25664023
Anesth Analg. 1995 Jun;80(6):1158-62
pubmed: 7762845
Acta Anaesthesiol Taiwan. 2004 Sep;42(3):175-8
pubmed: 15551897
Eur J Clin Pharmacol. 2018 Oct;74(10):1201-1214
pubmed: 29858921
Int J Surg Case Rep. 2016;23:74-6
pubmed: 27100952
Anesth Analg. 1998 Aug;87(2):347-54
pubmed: 9706929
Am J Physiol. 1990 Feb;258(2 Pt 2):H466-72
pubmed: 2309912
J Anaesthesiol Clin Pharmacol. 2015 Jul-Sep;31(3):329-32
pubmed: 26330710
Clin Pract. 2015 Feb 17;5(1):668
pubmed: 25918626
J Am Coll Cardiol. 1983 Jan;1(1):90-102
pubmed: 6826948
Front Pharmacol. 2017 Feb 21;8:68
pubmed: 28270765
Can J Anaesth. 2004 Mar;51(3):226-30
pubmed: 15010403
Anesth Analg. 2000 Jun;90(6):1390-5
pubmed: 10825326
Int J Obstet Anesth. 2014 May;23(2):138-43
pubmed: 24631057
J Anesth. 2018 Feb;32(1):90-97
pubmed: 29243058
Int J Obstet Anesth. 2012 Jan;21(1):24-8
pubmed: 22100822
Jpn J Pharmacol. 1995 Dec;69(4):351-6
pubmed: 8786638

Auteurs

Claudia Neumann (C)

Department of Anesthesiology and Intensive Care Medicine.

Markus Velten (M)

Department of Anesthesiology and Intensive Care Medicine.

Cornelia Heik-Guth (C)

Department of Anesthesiology and Intensive Care Medicine.

Brigitte Strizek (B)

Department of Gynecology and Obstetrics, University Hospital Bonn, Bonn, Germany.

Maria Wittmann (M)

Department of Anesthesiology and Intensive Care Medicine.

Tobias Hilbert (T)

Department of Anesthesiology and Intensive Care Medicine.

Sven Klaschik (S)

Department of Anesthesiology and Intensive Care Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH